Silpa Nuthalapati

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 3

Top Topics

Coronavirus Disease

Top Venues

Clinical pharmacology and therapeutics

Clinical pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Mohamed-Eslam F Mohamed, Sandhya Girish, Rita Humeniuk, Silpa Nuthalapati, Amit Desai, Amita Datta-Mannan, Ferdous Gheyas, Jitendra Kanodia, Sravanthi Cheeti, Tong Zhu
Impact of COVID-19 on the Conduct and Design of Clinical Trials: IQ Consortium Perspective. Clinical pharmacology and therapeutics (2024)
Mohamed-Eslam F Mohamed, Sandhya Girish, Rita Humeniuk, Silpa Nuthalapati, Amit Desai, Amita Datta-Mannan, Ferdous Gheyas, Jitendra Kanodia, Sravanthi Cheeti, Tong Zhu
Impact of COVID-19 on the Conduct and Design of Clinical Trials: IQ Consortium Perspective. Clinical pharmacology and therapeutics 116 (1) (2024)
Silpa Nuthalapati, Wijith Munasinghe, Vincent Giranda, Hao Xiong
Clinical Pharmacokinetics and Mass Balance of Veliparib in Combination with Temozolomide in Subjects with Nonhematologic Malignancies. Clinical pharmacokinetics 57 (1) (2019)